Last Thursday, I presented my Data on our minimum 12 month Outcomes regarding Marrow Aspirate Concentrate derived Stem Cells for Osteoarthritis of the knee to the Regenexx 3rd Annual Conference. It was held at the Scientific and Research Institute in Thornton, Colorado. The baseline number included 118 patients. While I presented the customary orthopedic objective data on the patient cohort such as point scores, Range of motion, patient satisfaction, psychological profiles and pain scores, I introduced two new Scoring parameters: 1) Activity Scores and 2) Comparison to Knee Replacement Outcomes.
Activity Scores are increasingly recognized as an objective outcome measurement documenting results without superimposed psychological disability, sociological factors, and serves as a quantitative measure of how much rather than how well. We measured impact sports breaking them down into very active categories, active, moderate and mild categories. In each category, the patients who had undergone stem cell intervention scored very well in either returning to a prior level of activity recently abandoned or actually advancing to a higher category of activity. As an example, I saw a patient last week six weeks past stem cell intervention for osteoarthritis of the knee. He had presented for treatment when his ability to walk was less than a city block. He marched in six weeks post treatment without a smile indicating that he was dissatisfied, as he still needed to use a handrail for stairs. When I asked him how he got to the office for the six-week follow-up, he responded that he had walked from home. I then inquired how far? His response ” 3 and 1/2 miles”.
In comparing knee replacement outcomes to stem cell interventions, the mean functional score for patients who had received Total Knee Prosthesis at a minimum of one year was 67. In comparison, the functional score for BMAC Stem Cell interventions was 90.5. While it may be that the stem cell population was not exactly comparable to those who had received a Total Knee Replacement, you decide, knee replacement or try stem cells first.
Tags: arthritis, arthritis treatment, athletes, Bone Marrow Concentrate, Clinical Trial. Mitchell B. Sheinkop, Hip Replacement, Interventional Orthopedics, Mature Athlete, Orthopedic Surgeon, Osteoarthritis, Regenexx-SD, stem cells